MoneyWorks4Me

Lincoln Pharmaceuticals informs about revised disclosures

04 May 2023 Evaluate
Lincoln Pharmaceuticals has informed that the exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mahendra Gulabdas Patel & PACs.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..